Consolidated Edison, Inc. (ED) Stock Price Today
Aura AI Summary
Key Stats
- $39.78BMarket Cap
- -Volume
- UtilitiesSector
- $115.4652W High
- $95.3752W Low
- -Typical Hold Time
- $66.81BEnterprise Value
- 3.25%Div Yield
- -Trading Activity
Track Consolidated Edison, Inc. (ED) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Consolidated Edison, Inc. has traded between a low of $95.37 and a high of $115.46, highlighting its annual price range. Buy and sell Consolidated Edison, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Consolidated Edison, Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Most Recent News
Rocket Lab wins $397M contract to build and launch Flatellites for US Space Force tracking program
Rocket Lab has secured a $397 million contract from the U.S. Space Force to develop, launch, and operate advanced Flatellites under the Space-Based Airborne Moving Target Indicator (SB-AMTI) program. This initiative aims to enhance real-time airborne...

Bunge Global SA gains insider buy and analyst boost, with price target up 28%
Bunge Global SA saw a director purchase 1,500 shares at $107.60, signaling insider confidence. Analysts have set a mean price target of $138.30, implying a 28.3% upside, driven by strong Q2 performance in soybeans and softseeds that raised earnings o...

TWST's 19% revenue growth highlights strong tech leadership and market share gains.
Twist Bioscience Corp. (TWST) reported a 19% year-over-year revenue increase, demonstrating its strong technology leadership and expanding product portfolio that continue to drive market share gains. This growth reinforces confidence in TWST's long-t...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.